Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Smith

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
International Archives of Allergy and Immunology|February 10, 2015
Inhibition of allergen-induced basophil activation by ASM-024, a nicotinic receptor ligandBrittany M Watson, John Paul Oliveria, Graeme M Nusca, et al.
Respiratory Research|May 11, 2021
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristicsMark C Liu, Bradley Chipps, Xavier Munoz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2023
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic TherapyClaus Bachert, Amber U Luong, Philippe Gevaert, et al.
The European Respiratory Journal|June 26, 2021
Stopping <i>versus</i> continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)Wendy C Moore, Oliver Kornmann, Marc Humbert, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polypsLarry Borish, Noam A Cohen, Geoffrey Chupp, et al.
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.
Plos One|September 15, 2015
Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis VaccinesSteven G Smith, Kaatje Smits, Simone A Joosten, et al.
Biology|August 26, 2022
Mitochondrial Ultrastructure and Activity Are Differentially Regulated by Glycolysis-, Krebs Cycle-, and Microbiota-Derived Metabolites in MonocytesC Angélica Pérez-Hernández, M Maximina Bertha Moreno-Altamirano, Edgar O López-Villegas, et al.
Scientific Reports|September 29, 2018
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infectionMatthew K O'Shea, Rachel Tanner, Julius Müller, et al.
Frontiers in Immunology|April 5, 2021
Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of <i>Mycobacterium tuberculosis</i>Patrice A Mawa, Mateusz Hasso-Agopsowicz, Lawrence Lubyayi, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
International Archives of Allergy and Immunology|February 10, 2015
Inhibition of allergen-induced basophil activation by ASM-024, a nicotinic receptor ligandBrittany M Watson, John Paul Oliveria, Graeme M Nusca, et al.
Respiratory Research|May 11, 2021
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristicsMark C Liu, Bradley Chipps, Xavier Munoz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2023
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic TherapyClaus Bachert, Amber U Luong, Philippe Gevaert, et al.
The European Respiratory Journal|June 26, 2021
Stopping <i>versus</i> continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)Wendy C Moore, Oliver Kornmann, Marc Humbert, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polypsLarry Borish, Noam A Cohen, Geoffrey Chupp, et al.
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.
Plos One|September 15, 2015
Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis VaccinesSteven G Smith, Kaatje Smits, Simone A Joosten, et al.
Biology|August 26, 2022
Mitochondrial Ultrastructure and Activity Are Differentially Regulated by Glycolysis-, Krebs Cycle-, and Microbiota-Derived Metabolites in MonocytesC Angélica Pérez-Hernández, M Maximina Bertha Moreno-Altamirano, Edgar O López-Villegas, et al.
Scientific Reports|September 29, 2018
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infectionMatthew K O'Shea, Rachel Tanner, Julius Müller, et al.
Frontiers in Immunology|April 5, 2021
Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of <i>Mycobacterium tuberculosis</i>Patrice A Mawa, Mateusz Hasso-Agopsowicz, Lawrence Lubyayi, et al.
Pageof 9